Actinium Pharmaceuticals, Inc. (ATNM) stock
ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.08−0.27 (-20.00%)
Close on Nov 18, 2026Market cap $33.96MP/E 3.0Yield –
Actinium Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Actinium Pharmaceuticals's market cap was $49.99M on Nov 11, 2026, against $43.05M a year earlier. Over the last 5 years it ranged from $26.26M to $336.75M, with a median of $113.16M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $49.99M | +17.8% |
| 2025 | Dec 31, 2025 | $42.43M | +7.9% |
| 2024 | Dec 31, 2024 | $39.31M | -71.8% |
| 2023 | Dec 29, 2023 | $139.26M | -48.1% |
| 2022 | Dec 30, 2022 | $268.51M | +102.8% |
| 2021 | Dec 31, 2021 | $132.41M | +24.9% |
| 2020 | Dec 31, 2020 | $105.97M | +195.5% |
| 2019 | Dec 31, 2019 | $35.86M | -16.1% |
| 2018 | Dec 31, 2018 | $42.76M | -19.5% |
| 2017 | Dec 29, 2017 | $53.11M | +27.1% |
| 2016 | Dec 30, 2016 | $41.78M | -69.1% |
| 2015 | Dec 31, 2015 | $135.39M | -22.4% |
| 2014 | Dec 31, 2014 | $174.46M | +25.2% |
| 2013 | Dec 31, 2013 | $139.34M | +11558.1% |
| 2012 | Dec 31, 2012 | $1.20M | – |
See a number that looks wrong?